TrialAJR. American journal of roentgenology2015

CT perfusion as an imaging biomarker in monitoring response to neoadjuvant bevacizumab and radiation in soft-tissue sarcomas: comparison with tumor morphology, circulating and tumor biomarkers, and gene expression.

Avinash Kambadakone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.